Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial

By B. Eriksson, O. Dahl, N. Rosencher, A. Kurth, C. V. Dijk, S. Frostick, P. Kälebo, A. Christiansen, S. Hantel, R. Hettiarachchi and 2 more. Journal of Thrombosis and Haemostasis, 2007

1,051 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Internal Medicine

View Paper: https://www.semanticscholar.org/paper/0239d295c4c652cff22924f8151713a894668c25

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. E. Vandermeuelen
2. S. Kopp
3. T. Horlocker
4. W. Gogarten
5. L. Leffert
6. H. Benzon

Citations in the corpus

• Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition) (2018, methodology): “Dabigatran was not used if an indwelling epidural catheter remained in place for postoperative pain relief.(182,184,185)”